As an effective inflammatory mediator of TNF-α or endotoxin (LPS), HMGB1 may progressively exacerbate the inflammation and damage of the bile duct, intrahepatic cholestasis, and hyperbilirubinemia during the early stages of ACLF. The gene discussed is HMGB1; the disease is Hyperbilirubinemia.